GlyCylic®’s vehicle (glycolic acid) works to break the bonds between the outer layers of the wart, including dead skin cells, and open pathways for the Salicylic Acid to achieve deep penetration.
GlyCylic® - is the first wart remover formulated with salicylic acid (a beta-hydroxy acid), glycolic acid (an alpha-hydroxyl acid), and immunomodulatory, virucidal, anti-scarring, and antiseptic ingredients that condition the emerging skin and promote healing while minimizing swelling, irritation, inflammation, and scarring.
Understanding current market demographics and assessing the competition in your area are among the tips when creating a practice strategy for the coming year.
Completing one's charitable giving and making sure to maximize the contribution to one's retirement account are among the financial tips for physicians as the year comes to a close.
Editor’s Note: Make your end-of-year, tax-deductible gift to the APMA Educational Foundation at www.apma.org/donate.
Problems with clinical documentation and poor interoperability were among the top reasons physicians cited for switching EHR systems, according to a recent survey.
Get your evenings back and simplify admin with Power Diary, ISO 27001 and HIPAA-certified practice management software. Save time with synced calendars, online bookings, two-way SMS messaging, SOAP notes, and more! Switch effortlessly with free data migration. Plans start at just $9.50 per month for the first six months and include the full suite of services – over 100 in-app features.
Disclaimer: Stories from sources other than APMA do not necessarily reflect APMA positions or policies. APMA does not endorse these stories. This content appears in the News Brief to enhance members' understanding of how media coverage shapes perceptions of podiatric medicine, and to educate members about what their patients, legislators and other healthcare professionals are seeing in the media.
